MIAMI, June 22, 2021 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a COVID-19 testing program for U.S. based crew and guests who cruise with Royal Caribbean Group, helping provide a safe environment for travelers. Under the agreement, unvaccinated guests will be required to undergo rapid, point-of-care PCR COVID-19 prior to embarking. These guests will […]
Category Archives: Press Release
Press Release
Major League Soccer Renews BioReference Laboratories as COVID-19 Testing Provider for Second Year
27
Apr
Apr
BioReference continues providing PCR molecular and rapid COVID-19 testing to Major League Soccer players, match officials, and Club and League employees BioReference is testing New England Revolution Fans for COVID-19 at Gillette Stadium in Foxborough, Massachusetts ELMWOOD PARK, N.J., April 27, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), announced its renewal as […]
Press Release
BioReference Laboratories Expands Its Major League Sports Relationships with Addition of Major League Baseball
01
Apr
Apr
ELMWOOD PARK, N.J., April 1, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced a COVID-19 testing agreement for players and staff, stadium employees and league staff for the 2021 Major League Baseball (MLB) season. Under the agreement with MLB, BioReference will provide on-site rapid PCR point-of-care COVID-19 testing to all […]
SPOKANE, Wash., March 30, 2021 /PRNewswire/ — Gestalt Diagnostics today announced, that BioReference Laboratories Inc., an OPKO Health company, has selected their digital pathology solution, PathFlow®, to support its pathology business. PathFlow is an enterprise software platform specifically designed to bring the benefits of digital workflow to pathologists and pathology laboratories. Under the agreement, Gestalt is partnering […]
BioReference is currently testing students and staff from two of the five largest school districts in the nation and is prepared to rapidly expand COVID-19 school testing to other school districts across the country ELMWOOD PARK, N.J., March 26, 2021 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the expansion of its COVID-19 school […]
Press Release
New York State Partners with BioReference Laboratories to Spearhead the NY Forward COVID-19 Rapid Test Program to Help Reopen the New York Economy
22
Feb
Feb
Locations now open in NYC with more to follow across the State NEW YORK CITY, February 22, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), announced its participation in the NY Forward Rapid Testing Program and opened eight locations offering COVID-19 rapid testing around New York. This program is designed to provide New Yorkers, and those visiting, with inexpensive and rapid COVID-19 testing. NY Forward is a collaboration with The Empire State Development Corporation, The Real Estate Board of New York (REBNY), the […]
Press Release
OPKO Health’s GeneDx Adds Repeat Expansion Analysis Genetic Tests for Diagnosis of Spinocerebellar Ataxia (SCA), Friedreich Ataxia, and Other Common Forms of Hereditary Ataxia
26
Jan
Jan
GAITHERSBURG, Md., January 26, 2021 — GeneDx, Inc., a wholly owned subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today launched several new genetic tests, including repeat expansion analysis for spinocerebellar ataxia (SCA), Friedreich ataxia, and other common forms of hereditary ataxias. With these additions, GeneDx has created a comprehensive and affordable offering that covers the […]
Press Release
OPKO Health’s BioReference Laboratories Team-up with the National Basketball Association and National Hockey League to Provide Players and Staff with COVID-19 Testing
26
Jan
Jan
BioReference executes COVID-19 testing program for NBA and NHL for 2020-21 seasons, as well as U.S. Women’s and Men’s National Soccer Teams, Winter X Games and NBA G League ELMWOOD PARK, N.J., January 26, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced COVID-19 testing agreements for players and officials, as well […]
Press Release
OPKO Health’s BioReference Laboratories Introduces Scarlet Health™, an In-Home Diagnostic Service to Expand Digital Health Access
13
Jan
Jan
Scarlet brings diagnostic service to patients’ homes, offices and other preferred locations, delivering an on-demand, safe and convenient diagnostic experience for patients and healthcare providers ELMWOOD PARK, N.J., January 13, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today introduced Scarlet Health™, an in-home, fully integrated digital platform providing access to on-demand diagnostic […]
Press Release
OPKO Health’s BioReference Laboratories Reports Results of the Largest COVID-19 Public School Testing Program Nationwide
04
Jan
Jan
Nearly 210,000 New York City students, teachers, principals and staff were tested by BioReference with a positivity rate of 0.47% ELMWOOD PARK, N.J., (January 4, 2021) – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced the results of COVID-19 molecular PCR tests for public schools throughout New York City’s boroughs, with a positivity rate of […]